Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 77 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				40 to 90				Pharmaceutical / Industry				AVO108943 NCT00470834


2.		Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				50 and over				Other				G050103 NCT00295802


3.		Phase III Randomized Trial of Suicide Gene Therapy and Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				Prostate4809 P01 CA098012, NCT00583492


4.		Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Not specified				Other				05-007 NCT00142506


5.		Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				553 NCT00132301

Last Modified: 7/30/2008 First Published: 6/9/2006


6.		Phase III Randomized Study of Pomegranate Extract in Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiotherapy for Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				ROLL-GUP-0205-1 UCLA-0507059-01, NCT00336934

Last Modified: 10/10/2008 First Published: 1/25/2007


7.		Phase III Randomized Study of Radical Prostatectomy With Versus Without Neoadjuvant Chemohormonal Therapy Comprising Docetaxel and Androgen-Deprivation Therapy With Leuprolide Acetate or Goserelin in Patients With High-Risk, Clinically Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-90203 CALGB-90203, NCT00430183


8.		A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				XRP6976J/3503 EudraCT#:2007-000323-17, NCT00514917


9.		A Phase III Trial of ZD4054 (Endothelin A Antagonist) in Non-Metastatic Hormone Resistant Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				D4320C00015 NCT00626548


10.		Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				GP/C/04/PRO NCT00630799

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute